V. Athyrou

Attaining United Kingdom-European Atherosclerosis Society Low-density Lipoprotein Cholesterol Guideline Target Values in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

D. Mikhailidis, V. Athyros, A. Papageorgiou, 2002, Current medical research and opinion.

Atorvastatin versus Four Statin–Fibrate Combinations in Patients with Familial Combined Hyperlipidaemia

V. Athyros, A. Papageorgiou, A. Pehlivanidis, 2002, Journal of cardiovascular risk.

Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia

V. Athyros, A. Papageorgiou, V. Athyros, 1998, Clinical drug investigation.

Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

V. Athyros, A. Papageorgiou, A. Symeonidis, 2002, Current medical research and opinion.

Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.

V. Athyros, A. Papageorgiou, V. Athyrou, 2002, Diabetes care.